Browse the evidence

Body food choice congruence is significantly higher in individuals with exercise addiction compared to those at risk of addiction.

Understanding food choice congruence may help in addressing exercise addiction.

Individuals at risk of exercise dependence have significantly lower average daily intakes of several nutrients compared to those at an addicted level.

Nutritional counseling may be beneficial for individuals at risk of exercise addiction.

The guidelines mostly agree, although there are slight differences in their recommendations.

Practitioners should be aware of both the consensus and differences in the guidelines.

A 6-month dietary intervention producing a 500 kcal/day energy deficit yields similar weight loss outcomes regardless of an individual's high or low genetic predisposition to higher BMI, as measured by genome-wide polygenic scores.

If you are overweight or mildly obese, a standard dietary intervention creating a 500 kcal/day deficit will likely help you lose weight, regardless of your genetic risk for obesity. You do not need a specialized or 'genetic' diet to succeed; standard caloric restriction is effective for everyone in this range.

Intermittent Fasting (IF) is defined as repetitive fasting periods lasting up to 48 hours each, including Time-Restricted Eating (TRE) and Alternate-Day Fasting (ADF).

Intermittent Fasting means you fast repeatedly, with each fast lasting no more than 48 hours. This includes popular methods like Time-Restricted Eating (eating within a daily window) and Alternate-Day Fasting. You do not need to restrict calories during eating windows if you choose TRE.

Time-Restricted Eating (TRE) is defined as restricting food and caloric beverage intake to a specific daily period, resulting in a fasting window of at least 14 hours, with no explicit limit on energy intake during eating hours.

Practice Time-Restricted Eating by limiting your daily food and calorie-containing drink consumption to a window of at least 14 hours. You do not need to restrict the amount of food you eat during this window.

Total daily energy expenditure (TDEE) in healthy, free-living, non-athlete individuals is primarily composed of resting energy expenditure (approx. 60%), physical activity energy expenditure (approx. 30%), and the thermic effect of food (approx. 10%).

To understand your daily energy needs, recognize that most energy (60%) is used just to keep your body running at rest, about 30% goes to movement, and 10% is used to digest food. This breakdown helps in estimating caloric requirements for health maintenance.

Physical activity energy expenditure (PAEE) is highly variable among individuals and can range from almost none in bedridden individuals to approximately 50% of TDEE in highly active individuals.

Your physical activity level is the most variable component of your daily energy expenditure. Increasing your movement can significantly increase your total energy needs.

Current pharmacological treatments for obesity, including incretin-based therapies (semaglutide, tirzepatide), result in significant skeletal muscle loss (approx. 7-10% of lean mass) alongside fat loss.

If you are using GLP-1 medications, expect to lose some muscle. You must actively combat this by eating enough protein and doing resistance training to preserve your metabolic engine.

Among patients with type 2 diabetes in placebo-controlled trials, baseline BMI has significantly increased over time (rising by ~0.70 kg/m² per decade), indicating a growing prevalence of obesity and inadequate management of weight despite improved glycemic control.

If you have Type 2 Diabetes, your weight is likely increasing even if your blood sugar is controlled. This meta-analysis of over 260,000 patients shows that baseline BMI has risen by 0.7 kg/m² every decade. You cannot ignore weight management; it is becoming harder, not easier, to maintain a healthy weight with current standard care. Focus on energy balance (diet and activity) as rigorously as you focus on glucose numbers.

Metabolic bariatric surgery is the most effective treatment for obesity across all BMI classes, offering durable weight loss and improvement in comorbidities.

For eligible patients (BMI ≥35, or 30-34.9 with failed lifestyle/pharma), metabolic bariatric surgery (sleeve or bypass) is the most effective treatment for durable weight loss and comorbidity improvement. It is recommended for BMI ≥35 regardless of comorbidities.

Intermittent fasting (IMF) and daily caloric restriction (DCR) produce equivalent weight loss when matched for energy deficit and delivered with guideline-based behavioral support and physical activity prescriptions.

To lose weight effectively, you can choose either daily calorie restriction or intermittent fasting, but the key is consistency and support. Ensure your total weekly energy deficit is similar regardless of the method. Crucially, engage in a structured behavioral support program that includes regular check-ins, goal setting, and physical activity (aiming for 300 minutes of moderate exercise per week). This structured approach is more important than the specific timing of your meals for long-term success.

High body-mass index (BMI) is a significant metabolic risk factor with increasing exposure rates (1.8% annually) and a 15.7% rise in age-standardized DALY rates from 2000 to 2021.

High BMI is a significant metabolic risk factor with increasing exposure rates. Addressing high BMI is crucial for long-term health.

Ketone bodies (KBs) serve as an efficient energy source that bypasses glycolysis, promoting mitochondrial oxidative metabolism and reducing oxidative stress.

Your brain can run efficiently on ketone bodies produced by the ketogenic diet. These molecules enter the Krebs cycle directly, bypassing the slower glycolytic pathway, which enhances mitochondrial energy production and reduces oxidative stress. This metabolic shift is central to the diet's benefits for neurological and metabolic health.

Mitochondrial impairment accelerates epigenetic aging, while enhancing mitochondrial biogenesis slows it, establishing a direct link between mitochondrial function and the rate of epigenetic aging.

Mitochondrial health is a key driver of epigenetic aging. Impairing mitochondria accelerates the epigenetic clock, while boosting mitochondrial biogenesis slows it. This suggests that interventions supporting mitochondrial function (like exercise or specific nutrients) may slow epigenetic aging, independent of DNA repair or telomere length.

Bariatric surgery is not first-line therapy for women of reproductive age hoping to conceive quickly due to risks of nutrient deficiencies and the required 1-2 year delay before pregnancy.

Avoid bariatric surgery if you plan to get pregnant soon. It requires a 1-2 year wait and can cause vitamin deficiencies that harm the baby. Use weight loss medications instead.

Lean mass is an inaccurate proxy for muscle mass in GLP-1 trials because it includes organs, bone, and fluids; MRI-based muscle volume z-scores provide a more accurate assessment of muscle health.

Do not rely solely on 'lean mass' numbers from standard scales or DXA scans to judge your muscle health. These numbers include water and organ weight. For a true picture of muscle, look at muscle volume and quality via advanced imaging like MRI, which shows if muscle fat is decreasing.

Increased economic development and industrialization are associated with higher obesity rates primarily due to increased caloric intake and diet quality (specifically ultraprocessed foods), rather than reduced physical activity or energy expenditure.

Stop blaming your lack of exercise for your weight gain. This research shows that moving less doesn't necessarily mean you burn significantly less energy than a highly active person of the same size. The real driver of obesity in modern societies is what you eat, specifically the high proportion of ultraprocessed foods that disrupt satiety and increase absorption. Focus on reducing ultraprocessed food intake rather than obsessing over increasing physical activity expenditure to fix obesity.

Intensive lifestyle intervention (ILI) focused on weight loss does not significantly reduce all-cause mortality in older adults with type 2 diabetes and overweight/obesity compared to diabetes support and education (DSE) over a median of 16.7 years.

For older adults with type 2 diabetes, engaging in intensive lifestyle programs (diet and exercise) is recommended to improve quality of life, fitness, and metabolic health, but should not be undertaken with the expectation that it will significantly extend lifespan compared to standard diabetes education. The intervention is safe and does not increase mortality risk.

Creatine supplementation does not significantly affect fat mass (FM), BMI, or body fat percentage (BFP) in the general population, although specific loading protocols with maintenance phases may lead to modest BFP reductions.

Do not take creatine expecting it to burn fat or change your body fat percentage. It will not significantly affect your fat mass or BMI. Its primary benefit is adding lean muscle mass when combined with resistance training.

Current rates of WMT utilization among patients with obesity are low, increasing from 5.3% to 7.1%.

Efforts should be made to increase the utilization of WMT among patients with obesity.

Treatment persistence was high, with 80% of patients completing 6 months of therapy.

High treatment persistence suggests that patients are likely to continue tirzepatide therapy.

Gastrointestinal adverse events were the most frequently reported but rarely led to treatment discontinuation.

Practitioners should monitor for gastrointestinal side effects but can expect them to be manageable.

There is a need for more accurate measures of muscle mass and function for diagnosing sarcopenia.

Practitioners should seek to utilize more accurate measurement tools for assessing sarcopenia.